Could a simple algorithm help doctors write better exercise prescriptions?

NCT ID NCT07238556

First seen Jun 26, 2026 · Last updated Aug 13, 2026 · Updated 3 times

Summary

This study tests a new digital tool called P3-EX that helps doctors create personalized exercise plans for patients with heart disease risk factors like high blood pressure, diabetes, and obesity. Researchers will recruit 24 doctors and 48 patients to compare the new tool with a standard exercise questionnaire. The goal is to see if doctors find the tool easy to use and if patients stick with their exercise program and show improvements in their health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
personalized exercise prescription (P3-EX algorithm)
What this could lead to
If successful, this tool could help doctors easily prescribe safe, effective exercise plans tailored to each patient, potentially improving heart health and reducing risk factors.
What could go wrong
This is a small, early feasibility study (72 participants) testing a digital tool, not a treatment itself. It may not show clear health benefits, and results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hartford HealthCare

    RECRUITING

    Hartford, Connecticut, 06102, United States

  • UConn Health

    NOT_YET_RECRUITING

    Farmington, Connecticut, 06030, United States

  • University of Connecticut

    RECRUITING

    Storrs, Connecticut, 06269, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.